Net Income (Loss) Attributable to Parent in USD of CITIUS ONCOLOGY, INC. from Q1 2021 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
CITIUS ONCOLOGY, INC. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q1 2021 to Q2 2025.
  • CITIUS ONCOLOGY, INC. Net Income (Loss) Attributable to Parent for the quarter ending 30 Jun 2025 was -$5.37M, a 12.5% decline year-over-year.
  • CITIUS ONCOLOGY, INC. Net Income (Loss) Attributable to Parent for the twelve months ending 30 Jun 2025 was -$26.6M, a 87.5% decline year-over-year.
  • CITIUS ONCOLOGY, INC. annual Net Income (Loss) Attributable to Parent for 2024 was -$21.1M, a 974% decline from 2023.
  • CITIUS ONCOLOGY, INC. annual Net Income (Loss) Attributable to Parent for 2023 was $2.42M, a 535% increase from 2022.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

CITIUS ONCOLOGY, INC. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 -$26.6M -$5.37M -$597K -12.5% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025
Q1 2025 -$26M -$7.74M -$2.9M -60% 01 Jan 2025 31 Mar 2025 10-Q 12 Aug 2025
Q4 2024 -$23.1M -$6.66M -$1.93M -40.9% 01 Oct 2024 31 Dec 2024 10-Q 12 Aug 2025
Q3 2024 -$21.1M -$6.81M -$6.97M -4414% 01 Jul 2024 30 Sep 2024 10-K 27 Dec 2024
Q2 2024 -$14.2M -$4.77M -$5.39M -874% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025
Q1 2024 -$8.79M -$4.84M -$5.45M -890% 01 Jan 2024 31 Mar 2024 10-Q 12 Aug 2025
Q4 2023 -$3.34M -$4.73M 01 Oct 2023 31 Dec 2023 10-Q 12 Aug 2025
Q3 2023 $158K 01 Jul 2023 30 Sep 2023 10-Q 20 Nov 2023
Q2 2023 $616K 01 Apr 2023 30 Jun 2023 10-Q 09 Aug 2024
Q1 2023 $612K 01 Jan 2023 31 Mar 2023 10-Q 09 Aug 2024
Q2 2021 -$724* 01 Apr 2021 30 Jun 2021 10-Q 28 Nov 2022
Q1 2021 -$9.39K 01 Mar 2021 31 Mar 2021 10-Q 28 Nov 2022

CITIUS ONCOLOGY, INC. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$21.1M -$23.6M -974% 01 Oct 2023 30 Sep 2024 10-K 27 Dec 2024
2023 $2.42M +$2.04M +535% 01 Jan 2023 31 Dec 2023 10-K 16 Apr 2024
2022 $381K 01 Jan 2022 31 Dec 2022 10-K 16 Apr 2024
* An asterisk sign (*) next to the value indicates that the value is likely invalid.